Summary & Overview
HCPCS J0461: Injection, Atropine Sulfate 0.01 mg
HCPCS Level II code J0461 denotes an injectable dose of atropine sulfate at 0.01 mg. This code captures administration of a low-dose antimuscarinic agent used in acute and procedural settings where precise, small-dose atropine is clinically indicated. Nationally, accurate coding of J0461 matters for correct billing, medication tracking, and clinical documentation, especially in emergency and perioperative care where atropine use can be time-sensitive.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for low-dose atropine administration, typical sites of service where J0461 is used, and the payer mix relevant to national billing practice. The publication provides benchmarks for coding prevalence, notes on common billing modifiers and service-line placement, and highlights policy or reimbursement updates affecting injectable medication codes.
This summary equips clinicians, billing professionals, and policy analysts with a concise reference to the clinical purpose of J0461, the payer environment, and the types of operational and coding considerations that commonly arise with low-dose atropine injections. Data not available in the input will be identified as such in the detailed sections.
Billing Code Overview
HCPCS Level II code J0461 represents an injection of atropine sulfate, 0.01 mg. The service is a single-dose injectable medication administration intended for therapeutic use when a small, precise dose of atropine is required.
Service Type: Medication administration — injectable antimuscarinic agent
Typical Site of Service: Outpatient clinic, emergency department, ambulatory surgery center, or inpatient hospital depending on clinical need and setting.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or preoperative area with symptomatic bradycardia, organophosphate poisoning, or asystolic arrest where a small, precise dose of atropine sulfate is indicated. The attending physician (emergency medicine, critical care, or anesthesia) orders J0461 for administration of 0.01 mg atropine solution via intramuscular or intravenous injection. Nursing documents vital signs, indication, dose, route, lot number, and patient response. The workflow includes medication order entry, informed consent when feasible, bedside administration by a licensed nurse or advanced practice provider, monitoring for anticholinergic side effects (tachycardia, dry mouth, pupillary dilation), and inclusion of the drug administration in the medical record and billing using J0461 with an appropriate modifier as needed for payer or clinical circumstances.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the same day | When an E/M visit is provided and documented separately from the injection service |